Pfizer Inc. (PFE): Make Money From Alzheimer’s Disease Whether Drugs Succeed or Not
From Insider Monkey - Free Hedge Fund and Insider Trading Data
January 31, 2013 - 4:02pm
A lot of high-profile drugs to treat Alzheimer’s disease reported data over the last year. Medivation, Inc. (NASDAQ:MDVN) and Pfizer Inc. (NYSE:PFE)‘s Dimebon last January. Data from the phase 3 program for bapineuzumab, owned by Pfizer, Johnson & Johnson (NYSE:JNJ) , and Elan (NYSE:ELN) , was released in the middle of last year, which was followed by Eli [...]
Continue reading this article »Share This Article: